drugset / Trial / NCT00472017

Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma

NCT00472017

Phase 1 Completed 35 enrolled St. Jude Children's Research Hospital
NaSingle-groupOpen-labelTreatment

Summary

This phase I trial is studying the side effects and best dose of vandetanib when given together with radiation therapy in treating young patients with newly diagnosed diffuse brain stem glioma.

Timeline

Start
2007-04
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Vandetanib Small molecule Oral